Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity

Nutrition and Diabetes

Volumn 5, Issue , 2015, Pages

  Duly, A M P ^a   Alani, B ^a   Huang, E Y W ^a   Yee, C ^b   Haber, P S ^b,c   McLennan, S V ^b,c   Seth, D ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ALCOHOL; CHOLESTEROL; COLLAGEN TYPE 1; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINGE DRINKING; BIOCHEMISTRY; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET INDUCED OBESITY; FATTY LIVER; FIBROGENESIS; HISTOPATHOLOGY; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER INJURY; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 84928722360     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2015.4     Document Type: Article

References (21)

1. Murphy SL, Xu J, Kochanek DK, Deaths MA. Preliminary Data for 2010. National Vital Statistics Reports, vol. 60, 2012. National Center for Health Statistics: Hyattsville, MD.
2. Deloitte. The Economic Cost and Health Burden of Liver Diseases in Australia. The Gastroenterological Society of Australia/Australian Liver Association, 2013. Deloitte Access Economics Pty Ltd: Canberra, Australia. pp 1-90.
3. Haber PS, Seth D, Warner D, Gorrell MD, McCaughan GW. Pathogenesis and management of alcoholic hepatitis. J Gastroenterol Hepatol 2003; 18: 1332-1344.
4. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-1219.
5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
6. Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 2007; 18: 184-195.
7. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145-171.
8. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002; 35: 1485-1493.
9. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010; 340: c1240.
10. Liu B, Balkwill A, Reeves G, Beral V. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ 2010; 340: c912.
11. Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 2013; 8: 627-637.
12. Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, McCaughan GW et al. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol 2011; 55: 435-444.
13. Byun J-S, Suh Y-G, Yi H-S, Lee Y-S, Jeong W-I. Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J Hepatol 2013; 58: 342-349.
14. Xu J, Lai KKY, Verlinsky A, Lugea A, French SW, Cooper MP et al. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 2011; 55: 673-682.
15. Seth D, Hogg PJ, Gorrell MD, McCaughan GW, Haber PS. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver diseaseq. J Hepatol 2008; 48: 614-627.
16. Seth D, Cordoba S, Gorrell MD, McCaughan GW, Haber PS. Intrahepatic gene expression in human alcoholic hepatitis. J Hepatol 2006; 45: 306-320.
17. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C et al. Upregulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 2000; 141: 4021-4031.
18. Hebbachi AM, Knight BL, Wiggins D, Patel DD, Gibbons GF. Peroxisome proliferator-activated receptor deficiency abolishes the response of lipogenic gene expression to re-feeding. J Biol Chem 2008; 283: 4866-4876.
19. Miller CW, Nitamni JM. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci USA 1996; 93: 9443-9448.
20. Knight BL, Hebbachi A, Hauton D, Brown A-M, Wiggins D, Patel DD et al. A role for PPARα in the control of SREBP activity and lipid synthesis in the liver. Biochem J 2005; 389: 413-421.
21. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T et al. 'New' hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 2005; 1: 309-322.